FORWARD PHARMA A/S's ticker is FWP and the CUSIP is 34986J105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $0 | – | 7 | +75.0% | 0.00% | – |
Q2 2019 | $0 | -100.0% | 4 | -90.5% | 0.00% | – |
Q4 2015 | $1,000 | 0.0% | 42 | -32.3% | 0.00% | – |
Q3 2015 | $1,000 | -50.0% | 62 | 0.0% | 0.00% | – |
Q2 2015 | $2,000 | +100.0% | 62 | +26.5% | 0.00% | – |
Q1 2015 | $1,000 | – | 49 | +390.0% | 0.00% | – |
Q4 2014 | $0 | – | 10 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 1,441,287 | $27,384,000 | 4.67% |
Monashee Investment Management LLC | 81,805 | $1,554,000 | 3.09% |
Baupost Group | 5,367,300 | $101,979,000 | 1.85% |
Sio Capital Management, LLC | 100,000 | $1,900,000 | 0.84% |
Cormorant Asset Management, LP | 335,068 | $6,366,000 | 0.76% |
EcoR1 Capital, LLC | 100,017 | $1,900,000 | 0.60% |
Assured Investment Management LLC | 1,102,924 | $20,956,000 | 0.37% |
SPHERA FUNDS MANAGEMENT LTD. | 121,500 | $2,309,000 | 0.34% |
HELLMAN JORDAN MANAGEMENT CO INC /MA/ | 62,769 | $1,192,000 | 0.29% |
Orbimed Advisors | 960,600 | $18,251,000 | 0.16% |